Nerve stimulation might ease fibromyalgia pain

June 10, 2013 by Maureen Salamon, Healthday Reporter
Nerve stimulation might ease fibromyalgia pain
Small early study saw improvement in patients' quality of life.

(HealthDay)—An implanted device that zaps the nerves at the nape of the neck—shown effective in treating some people with migraines—may also help ease the ache of fibromyalgia, an ailment that causes widespread body pain and tenderness.

A Belgian scientist treated small numbers of fibromyalgia patients with "occipital nerve stimulation," which rouses the occipital nerves just beneath the skin at the back of the neck using an implanted device. Dr. Mark Plazier found that dropped for 20 of 25 patients using this device over six months and their quality of life improved significantly.

"There are only a few treatment options [for fibromyalgia] right now and the response to treatment is far from 100 percent, which implies there are a lot of patients still looking for help to get a better life. This treatment might be an excellent option for them," said Plazier, a at University Hospital Antwerp. But, "it is difficult to determine the impact of these findings on fibromyalgia patients, since larger trials ... are necessary."

Plazier is to present his research this week at a meeting of the International Neuromodulation Society, in Berlin. Neuromodulation is a group of therapies that use medical devices to relieve symptoms or restore abilities by altering function.

Research presented at scientific conferences has not typically been peer-reviewed or published and is considered preliminary.

Fibromyalgia is thought to affect about 5 million American adults—most of them women—according to the U.S. National Institutes of Health. The cause of the disorder, which can also involve , , is unknown and it can be difficult to treat.

Plazier also presented a separate study on six fibromyalgia patients using images to visualize from occipital nerve stimulation treatment. It suggested that the nerve stimulation changes activity in the , a brain region that helps determine pain perception.

"In fibromyalgia, we see that there is a hypervigilance to pain, so patients are more sensitive to pain and more aware of it," Plazier said. "They also have high scores on questionnaires concerning catastrophizing behavior, which implies the high impact of pain on their lives."

"During [occipital nerve] stimulation we see differences in brain activity on PET scans in regions involved in pain," he added. "This all might suggest that we are influencing a cerebral system and might even turn it back to 'normal' perception."

Study participants didn't find the nerve-zapping treatment to be painful, Plazier noted. The occipital nerve stimulation device is implanted during a brief surgery using general anesthesia, he said, and postoperative pain is normal but not extreme.

Dr. Patrick Wood, director of the fibromyalgia clinic at Madison River Oaks Medical Center in Canton, Miss., called the studied "interesting and promising" but said additional research is necessary before treatment with occipital nerve stimulation—which may cost around $10,000—could become mainstream for fibromyalgia patients.

"It's mostly used in headaches, and even in the headache realm it's still considered experimental," Wood said. "It would be nice to have expanded data here that would indicate there's something worth banking on and putting our hopes on. It's promising, but more work needs to be done before the average patient can consider it."

Explore further: Weather conditions do not affect fibromyalgia pain or fatigue

More information: The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases has more about fibromyalgia.

Related Stories

Weather conditions do not affect fibromyalgia pain or fatigue

June 4, 2013
Dutch researchers report that weather conditions including temperature, sunshine, and precipitation have no impact on fibromyalgia symptoms in female patients. Results published in Arthritis Care & Research, a journal of ...

Fatigue not a factor in fibromyalgia pain, study says

April 26, 2012
(HealthDay) -- Poor sleep is not a significant predictor of pain intensity and duration in patients with fibromyalgia, a new study says.

New Canadian guidelines for treating fibromyalgia

May 6, 2013
Physicians from the McGill University Health Centre (MUHC) and the University of Calgary have published a review article in the CMAJ (Canadian Medical Association Journal) to help family doctors diagnose and treat fibromyalgia. ...

Nursing research suggests mild electrical pulses may aid fibromyalgia sufferers

March 4, 2013
(Medical Xpress)—If mild cranial electrical stimulation helps lessen fibromyalgia pain, as studies seem to suggest, does it do this by changing activity in certain brain regions?

Nerve stimulation for severe depression changes brain function

May 7, 2013
For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy.

Regular, moderate exercise does not worsen pain in people with fibromyalgia

May 2, 2013
For many people who have fibromyalgia, even the thought of exercising is painful. Yet a new study from Wake Forest Baptist Medical Center shows that exercise does not worsen the pain associated with the disorder and may even ...

Recommended for you

Researchers developing new tool to distinguish between viral, bacterial infections

July 28, 2017
Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance. Researchers at the University of Rochester Medical Center are developing a tool to help physicians ...

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.